Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M223,065Revenue (TTM) $M50,992Net Margin (%)14.9Altman Z-Score2.6
Enterprise Value $M243,297EPS (TTM) $1.2Operating Margin %25.0Piotroski F-Score6
P/E(ttm)30.1Beneish M-Score-2.6Pre-tax Margin (%)18.5Higher ROA y-yN
Price/Book3.610-y EBITDA Growth Rate %2.6Quick Ratio1.2Cash flow > EarningsY
Price/Sales4.55-y EBITDA Growth Rate %0.6Current Ratio1.4Lower Leverage y-yY
Price/Free Cash Flow16.5y-y EBITDA Growth Rate %-14.6ROA % (ttm)4.6Higher Current Ratio y-yN
Dividend Yield %3.2PEG50.2ROE % (ttm)11.6Less Shares Outstanding y-yY
Payout Ratio %93.0Shares Outstanding M6,065ROIC % (ttm)12.1Gross Margin Increase y-yN

Gurus Latest Trades with PFE

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
PFET Rowe Price Equity Income Fund 2016-06-30 Reduce-0.11%$29.64 - $35.31
($33.58)
$ 36.7810%Reduce -5.36%13,941,800
PFELeon Cooperman 2016-03-31 Sold Out -0.91%$28.56 - $32.28
($30.14)
$ 36.7822%Sold Out0
PFEKahn Brothers 2016-03-31 Reduce-0.73%$28.56 - $32.28
($30.14)
$ 36.7822%Reduce -8.11%1,442,543
PFEJoel Greenblatt 2016-03-31 Buy 0.52%$28.56 - $32.28
($30.14)
$ 36.7822%New holding1,577,263
PFENWQ Managers 2016-03-31 Add0.25%$28.56 - $32.28
($30.14)
$ 36.7822%Add 28.00%2,518,601
PFEJohn Paulson 2016-03-31 Add0.17%$28.56 - $32.28
($30.14)
$ 36.7822%Add 117.81%1,378,100
PFEVanguard Health Care Fund 2016-03-31 Reduce-0.1%$28.56 - $32.28
($30.14)
$ 36.7822%Reduce -18.09%7,267,526
PFECharles Brandes 2016-03-31 Reduce-0.05%$28.56 - $32.28
($30.14)
$ 36.7822%Reduce -1.83%5,536,325
PFEDavid Tepper 2016-03-31 Add0.05%$28.56 - $32.28
($30.14)
$ 36.7822%Add 4.15%2,512,250
PFEDodge & Cox 2016-03-31 Reduce-0.04%$28.56 - $32.28
($30.14)
$ 36.7822%Reduce -58.56%929,604
PFEKen Fisher 2016-03-31 Reduce-0.04%$28.56 - $32.28
($30.14)
$ 36.7822%Reduce -1.82%31,746,148
PFEMario Gabelli 2016-03-31 Reduce-0.04%$28.56 - $32.28
($30.14)
$ 36.7822%Reduce -24.04%537,011
PFET Rowe Price Equity Income Fund 2016-03-31 Add0.03%$28.56 - $32.28
($30.14)
$ 36.7822%Add 1.42%14,730,900
PFEJohn Keeley 2016-03-31 Add0.03%$28.56 - $32.28
($30.14)
$ 36.7822%Add 34.41%104,500
PFEDavid Dreman 2016-03-31 Buy 0.02%$28.56 - $32.28
($30.14)
$ 36.7822%New holding5,820
PFEBarrow, Hanley, Mewhinney & Strauss 2016-03-31 Reduce-0.01%$28.56 - $32.28
($30.14)
$ 36.7822%Reduce -0.26%53,724,766
PFEFirst Eagle Investment 2016-03-31 Add$28.56 - $32.28
($30.14)
$ 36.7822%Add 3.98%141,061
PFERichard Pzena 2016-03-31 Add$28.56 - $32.28
($30.14)
$ 36.7822%Add 1.18%2,187,104
PFERuane Cunniff 2016-03-31 Reduce$28.56 - $32.28
($30.14)
$ 36.7822%Reduce -16.22%12,442
PFELeon Cooperman 2015-12-31 Reduce-2.24%$31.33 - $35.45
($33.17)
$ 36.7811%Reduce -73.18%1,295,600
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

PFE is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


PFE: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
DAMELIO FRANK AExecutive Vice President 2016-05-26Sell100,000$34.495.97view
CANGIALOSI LORETTA VSr. Vice President, Controller 2016-05-24Sell86,000$33.977.59view
OLSON LAURIE JExecutive Vice President 2016-05-11Sell4,700$33.59.1view
YOUNG JOHN DGroup President 2016-05-10Sell41,700$33.539.01view
DAMELIO FRANK AExecutive Vice President 2016-05-10Sell192,000$33.668.59view
READ IAN CChairman & CEO 2016-05-09Sell275,000$33.88.14view
SUSMAN SALLYExecutive Vice President 2016-05-09Sell67,884$33.718.42view
HILL CHARLES HExecutive Vice President 2016-05-09Sell29,600$33.848.01view
MADDALUNA ANTHONY JExecutive Vice President 2016-05-09Sell8,950$33.758.3view
SUSMAN SALLYExecutive Vice President 2016-05-05Sell76,116$33.758.3view

Quarterly/Annual Reports about PFE:

    News about PFE:

    Articles On GuruFocus.com
    Technology Earnings Helping Market to Gain Jul 20 2016 
    US Market Indexes Achieve New Highs Jul 14 2016 
    Investing in Big Pharma: Pointers on Pfizer Jul 14 2016 
    John Burbank's Best Investments Jul 14 2016 
    Investors Cautious in Trading as Stocks End Day Lower Jun 22 2016 
    U.S. Market Indexes Gain as Investors Await UK Vote Jun 21 2016 
    Pfizer, Merck, Other Big Pharmas Likely to Acquire Marijuana-Based Drug Companies Jun 13 2016 
    U.S. Stocks Trade Flat at Start of Week May 09 2016 
    UnitedHealth’s Obamacare Changes to Affect Healthcare Sector Apr 27 2016 
    Does Biotech’s Recent Bounce Have Legs? Apr 22 2016 

    More From Other Websites
    Zacks Industry Outlook Highlights: Bristol-Myers, Pfizer, Sanofi, Amgen and Biogen Jul 25 2016
    Spark Therapeutics and Pfizer Announce Updated Data from First Cohort in Hemophilia B Phase 1/2... Jul 25 2016
    Spark Therapeutics and Pfizer Announce Updated Data from First Cohort in Hemophilia B Phase 1/2... Jul 25 2016
    BIND Therapeutics Announces Two Bidders Join Pfizer's Stalking Horse Bid in Auction for BIND's... Jul 25 2016
    The Economy, Interest Rates, Earnings and the Markets Jul 25 2016
    Six Major Biotech Acquisitions You Could See in 2016 (Part 2) Jul 22 2016
    Will Pfizer Book Another Healthy Quarter? Jul 22 2016
    Facing Cancer Drug Shortage, U.S. Relies on Banned Chinese Plant Jul 21 2016
    How Analysts Think Investors Should Play Vertex Pharmaceuticals Jul 21 2016
    Is biotech back? Jul 21 2016
    Fresenius Bid for Pfizer’s Pumps Unit Said to Stall on Valuation Jul 21 2016
    Opioid Addiction: What To Do When A Loved One Is Hooked, According To Science Jul 21 2016
    Spark Therapeutics and Pfizer Announce Receipt of FDA Breakthrough Therapy Designation for SPK-9001... Jul 21 2016
    Dollars and Sense: The Companies that Should be on Your Watch List Jul 20 2016
    Beech Hill Advisors’ Top Stock Picks for Q3; Apple Inc. (AAPL) Leads the Pack Jul 20 2016
    2 Growth & Income Titans to Buy Today Jul 20 2016
    Dollars & Sense: Jim Lebenthal's Watchlist Jul 20 2016
    U.S. healthcare stock bulls look past political risks Jul 20 2016
    Why a Trump Win Could Be Good News for Pfizer, IBM Jul 19 2016
    Pfizer Announces the Publication of Final Results from Two Pivotal Phase 3 Studies of Crisaborole... Jul 13 2016
    Lower-cost biotech drug gets thumbs up from FDA panel Jul 12 2016
    Pfizer Receives FDA Approval for Prevnar 13® in Adults Age 18 Through 49 Jul 12 2016
    Pfizer Announces Positive Top-Line Results From Phase 3 S-TRAC Trial of SUTENT® (sunitinib) as... Jul 08 2016
    Pfizer agrees to note addiction risks in opioid marketing Jul 06 2016
    Merck KGaA, Darmstadt, Germany, and Pfizer Initiate Phase III Trial to Evaluate Avelumab as... Jul 06 2016
    Merck and Pfizer Initiate Phase III Trial to Evaluate Avelumab as First-line Treatment for Ovarian... Jul 06 2016
    Medivation agrees to open its books to Sanofi Jul 05 2016
    UK plans lower corporation tax to cushion hit from Brexit Jul 04 2016
    BIND Therapeutics Files Motion for Sale of Assets After Accepting Stalking Horse Bid from Pfizer... Jul 01 2016
    Two Additional Phase 3 Lipid-Lowering Studies of Bococizumab Deliver Positive Topline Results Jun 28 2016
    Pfizer Advances Biosimilars Leadership with Investment in a New World-Class Global Biotechnology... Jun 28 2016
    Pfizer Advances Biosimilars Leadership with Investment in a New World-Class Global Biotechnology... Jun 27 2016
    Pfizer Advances Biosimilars Leadership with Investment in a New World-Class Global Biotechnology... Jun 27 2016
    Pfizer Completes Acquisition Of Anacor Jun 24 2016
    Pfizer Completes Acquisition of Anacor Jun 24 2016
    Pfizer Declares 30-Cent Third-Quarter 2016 Dividend Jun 23 2016
    Pfizer Invites Public To View And Listen To Webcast Of August 2 Conference Call With Analysts Jun 21 2016
    Rx pizza: 1 free meal can sway doctor prescribing Jun 20 2016
    Oracle Announces Pfizer’s Selection of Oracle Cloud for Clinical Data Management and Trial... Jun 20 2016
    Pfizer Breaks Ground On New Biologics Clinical Manufacturing Facility In Andover, Massachusetts Jun 16 2016
    Shire buys bowel drug rights from Pfizer Jun 14 2016
    Merck and Pfizer Announce Two Pivotal Phase 3 Studies for Ertugliflozin, an Investigational SGLT-2... Jun 13 2016
    Pfizer Announces Final Results from Inotuzumab Ozogamicin Pivotal Phase 3 Study in Adults with... Jun 12 2016
    Fresenius, Smiths in two-way race for Pfizer infusion pumps - sources Jun 06 2016
    Fresenius, Smiths in 2-way race for Pfizer infusion pumps-sources Jun 06 2016
    Ex-Oppenheimer & Co. employee faces insider trading charges Jun 03 2016
    GSK's modern HIV drug to be rolled out in Botswana Jun 03 2016
    Pharma sector set for wave of mergers, acquisitions: study May 30 2016
    Anacor received rival bid before Pfizer deal - filing May 26 2016
    EU lifts suicide warning on Pfizer's smoking-cessation pill May 23 2016
    U.S. FDA approves Roche's immunotherapy for bladder cancer May 18 2016
    Pascal Soriot's big experiment: reinventing AstraZeneca May 18 2016
    AstraZeneca asthma drug hits goal, to enter competitive market May 17 2016
    Asian stocks mixed as crude oil rises, Chinese shares fall May 16 2016
    Business Highlights May 16 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)